Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
When To Use Bond Ladder Retirement Portfolio explains scenarios where a bond ladder can stabilize withdrawals and cushion market swings.
22,278 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
AMD delivered a strong Q1 FY2026, prompting a broad uprising in analyst targets. Nine firms boosted price targets as ...
Snap faces another disappointing quarter as ad revenue slows and user growth stalls. With mounting headwinds, many an...
A potential iran peace deal could ease energy pressures and ignite a renewed risk-on rally across stocks, with airlin...
A security flaw allowed a hacker to drain approximately $5.9 million from TrustedVolumes, a DeFi liquidity provider o...
Bitmine Immersion Technologies slows weekly ETH purchases while maintaining a bullish stance. Tom Lee signals a forth...
PropLogix launches PropOptix, a sales outreach platform that uses real-time market signals to connect title firms wit...
NVIDIA's market value has surged as AI infrastructure demand powers a relentless rally. A single metric—this insane n...
Two leading banks issued contrasting views on AMD in a single day, underscoring a broader divide in how investors pri...
Inflation cools unevenly as growth slows, and the fed’s worst-case scenario quietly unfolds. Investors reassess risk ...
Forget intel. executives cashing has raised caution among traders, but the AI demand backdrop remains intact. This pi...
As automation advances, hospitality leaders argue that Gen Z workers want ai-proof jobs with purpose. A 50-property c...